John Campbell

John Campbell is currently serving as the Chief Scientific Officer at Swarm Oncology and adthera bio. John is also an Executive In Residence at Delin Ventures. With a background in academia, John is a Founder and Advisor at Resolution Therapeutics and holds honorary professor positions at the University of Edinburgh and the University of Glasgow. Prior to this, John held key roles at SNBTS, Miltenyi Biotec, and the University of Glasgow. John holds a PhD in Pathology/Experimental Pathology from The University of Edinburgh and a BSc in Cell and Immunobiology from the University of Aberdeen.